0
Mappings
0
Definitions
1
Inheritance
7
Pathophysiology
0
Histopathology
6
Phenotypes
16
Pathograph
3
Genes
2
Treatments
0
Subtypes
0
Differentials
0
Datasets
0
Trials
0
Models
🏷

Classifications

Harrison's Chapter
hereditary disease
Mechanistic Nosology
ciliopathy
👪

Inheritance

1
Autosomal recessive inheritance HP:0000007
Classic Bardet-Biedl syndrome is an autosomal recessive syndromic ciliopathy.
Autosomal recessive inheritance
Show evidence (1 reference)
PMID:20876674 SUPPORT Human Clinical
"Bardet-Biedl Syndrome (BBS) is a rare autosomal recessive ciliopathy with a wide spectrum of clinical features including obesity, retinitis pigmentosa, polydactyly, mental retardation, hypogonadism, and renal abnormalities."
This cohort abstract explicitly states autosomal recessive inheritance for classic BBS.

Pathophysiology

7
Pathogenic BBS gene defects
Biallelic pathogenic variants in established BBS genes initiate classic Bardet-Biedl syndrome.
BBS1 link BBS10 link BBS2 link ARL6 link MKKS link
Show evidence (2 references)
PMID:30614526 SUPPORT Human Clinical
"Molecular diagnosis during pregnancies remains a timely challenge for this heterogeneous disease (22 known genes)."
This large prenatal molecular series supports disease initiation by biallelic pathogenic variants across many established BBS genes.
PMID:41219488 SUPPORT Human Clinical
"Biallelic pathogenic variants were identified in all patients, including three novel variants in the ARL6/BBS3, BBS9, and BBS10 genes, observed in four patients, including two siblings."
This recent cohort confirms that clinically diagnosed BBS is anchored by biallelic pathogenic variants in established BBS genes.
Defective BBSome assembly
Pathogenic variants in core BBSome subunits and chaperonin-like BBS proteins impair ordered assembly of the BBSome, the ciliary trafficking complex central to BBS biology.
BBSome link primary cilium link
Show evidence (2 references)
PMID:22500027 SUPPORT In Vitro
"Three additional BBS genes (BBS6, BBS10, and BBS12) have homology to type II chaperonins and interact with CCT/TRiC proteins and BBS7 to form a complex termed the BBS-chaperonin complex. This complex is required for BBSome assembly."
This mechanistic study directly supports chaperonin-dependent failure of BBSome assembly as an early causal step in BBS.
PMID:20080638 SUPPORT In Vitro
"Our data demonstrate that BBS6, BBS10, and BBS12 are necessary for BBSome assembly, and that impaired BBSome assembly contributes to the etiology of BBS phenotypes associated with the loss of function of these three BBS genes."
This complementary paper independently supports BBSome assembly failure as a proximal disease mechanism.
Ciliary membrane protein trafficking defect
Failure of an intact BBSome disrupts trafficking of signaling proteins and other cargos into and within the ciliary compartment.
protein localization to cilium link intraciliary transport link
primary cilium link
Show evidence (1 reference)
PMID:36699005 SUPPORT Model Organism
"GPCR ciliary localization is disrupted in neurons from mouse models of the ciliopathy Bardet-Biedl syndrome, with GPCRs failing to localize to cilia, indicating the Bardet-Biedl syndrome proteins are required for trafficking of G protein-coupled receptors into neuronal cilia."
This mouse study directly supports defective ciliary cargo trafficking as a general mechanistic consequence of BBS protein loss.
Hypothalamic leptin receptor signaling defect
BBS proteins are required for leptin-receptor trafficking and leptin-induced hypothalamic signaling, creating ciliary leptin resistance and impaired satiety signaling.
neuron link
JAK-STAT signaling link
hypothalamus link
Show evidence (2 references)
PMID:19150989 SUPPORT Model Organism
"Our data indicate that BBS proteins mediate LepR trafficking and that impaired LepR signaling underlies energy imbalance in BBS."
This mouse study directly connects BBS-protein loss to defective hypothalamic leptin receptor trafficking and signaling.
PMID:21209035 SUPPORT Human Clinical
"Patients with BBS had higher leptin than expected for their degree of adiposity, consistent with the notion that ciliopathy-induced leptin signaling dysfunction is associated with leptin resistance."
Human metabolic data support leptin resistance as a clinically observable consequence of BBS-related satiety-pathway dysfunction.
Photoreceptor outer-segment transport defect
In photoreceptors, defective ciliary transport mislocalizes rhodopsin and other outer-segment cargo, leading to photoreceptor degeneration.
photoreceptor cell link
photoreceptor outer segment link
retina link
Show evidence (1 reference)
PMID:15539463 SUPPORT Model Organism
"Photoreceptor cell death is preceded by mislocalization of rhodopsin, indicating a defect in transport."
This model-organism study directly ties BBS-related transport failure to the retinal degeneration branch of the disease.
Renal tubulointerstitial injury
Kidney involvement in BBS includes renal dysmorphism, impaired kidney function, and chronic tubulointerstitial disease consistent with a renal ciliopathy.
nephron tubule epithelial cell link
kidney link
Show evidence (1 reference)
PMID:20876674 SUPPORT Human Clinical
"Renal abnormalities, including impairment of renal function and signs of chronic interstitial nephropathy of dysplastic nature, were documented in 82% of the patients."
This human cohort provides direct tissue-level support for renal tubulointerstitial disease within BBS.
Altered Sonic hedgehog-dependent limb patterning
BBS loss perturbs cilia-dependent Sonic hedgehog signaling during limb-bud development, predisposing to postaxial digit duplication.
smoothened signaling pathway link
limb bud link
Show evidence (1 reference)
PMID:18381349 SUPPORT Model Organism
"We evaluated zebrafish fin bud patterning and observed altered Sonic hedgehog (shh) expression and subsequent changes to fin skeletal elements."
This in vivo developmental study supports altered hedgehog-dependent limb patterning as the mechanistic basis for BBS polydactyly.

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Bardet-Biedl syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.

Phenotypes

6
Eye 2
Rod-cone dystrophy VERY_FREQUENT Rod-cone dystrophy (HP:0000510)
Show evidence (2 references)
PMID:35886001 SUPPORT Human Clinical
"All patients had retinal dystrophy with morphologic changes of the retina."
This specialist ophthalmic cohort supports retinal dystrophy as an essentially invariant feature of molecularly confirmed BBS.
PMID:41219488 SUPPORT Human Clinical
"Retinal dystrophy was the most common feature (94.1%), followed by polydactyly (88.0%), obesity (68.0%), and renal anomalies (52.0%)."
This recent cohort provides direct frequency support for a very frequent retinal dystrophy phenotype.
Progressive visual loss Progressive visual loss (HP:0000529)
Show evidence (2 references)
PMID:35886001 SUPPORT Human Clinical
"Visual acuity decreased from ~0.2 (decimal) at age 5 to blindness 0 at 50 years."
This cohort provides direct longitudinal-style evidence for progressive loss of vision across the lifespan in BBS.
PMID:22358239 SUPPORT Human Clinical
"In a relatively young cohort of patients with Bardet-Biedl syndrome, only 21% had 20/40 or better vision."
This retinal-function study supports clinically important visual loss even in a relatively young cohort.
Genitourinary 1
Renal abnormalities FREQUENT Abnormality of the kidney (HP:0000077)
Show evidence (2 references)
PMID:20876674 SUPPORT Human Clinical
"Renal abnormalities, including impairment of renal function and signs of chronic interstitial nephropathy of dysplastic nature, were documented in 82% of the patients."
This national cohort supports renal involvement as a frequent and clinically important component of BBS.
PMID:41219488 SUPPORT Human Clinical
"Retinal dystrophy was the most common feature (94.1%), followed by polydactyly (88.0%), obesity (68.0%), and renal anomalies (52.0%)."
This recent cohort confirms that renal involvement remains common but more variable than retinal disease or polydactyly.
Limbs 1
Postaxial polydactyly FREQUENT Postaxial polydactyly (HP:0100259)
Show evidence (2 references)
PMID:41219488 SUPPORT Human Clinical
"Retinal dystrophy was the most common feature (94.1%), followed by polydactyly (88.0%), obesity (68.0%), and renal anomalies (52.0%)."
This recent cohort provides direct frequency support for polydactyly as a frequent primary BBS feature.
PMID:30614526 SUPPORT Human Clinical
"postaxial polydactyly (82%) and renal cysts (78%) were the most prevalent symptoms."
This large molecularly confirmed prenatal cohort provides independent support for frequent postaxial polydactyly.
Nervous System 1
Hyperphagia Polyphagia (HP:0002591)
Show evidence (1 reference)
PMID:23776152 SUPPORT Human Clinical
"Total hyperphagia questionnaire score was higher in BBS than controls (27.6 ± 9.0 vs. 19.1 ± 7.9, P = 0.005)."
This controlled study shows that hyperphagic symptoms are increased in BBS relative to BMI-matched controls.
Growth 1
Obesity FREQUENT Obesity (HP:0001513)
Show evidence (2 references)
PMID:32700463 SUPPORT Human Clinical
"Despite normal birth weight, most individuals with BBS experience rapid weight gain in early childhood, with high rates of overweight/obesity sustained through adolescence."
This large registry-based pediatric study supports obesity as a core and early feature of BBS.
PMID:41219488 SUPPORT Human Clinical
"Retinal dystrophy was the most common feature (94.1%), followed by polydactyly (88.0%), obesity (68.0%), and renal anomalies (52.0%)."
This recent cohort provides direct frequency support for obesity as a frequent BBS phenotype.
🧬

Genetic Associations

3
BBS1 (Pathogenic biallelic variants)
Show evidence (2 references)
PMID:28143435 SUPPORT Human Clinical
"The most common mutated gene was BBS1 followed by BBS10."
This Italian cohort identifies BBS1 as the most common gene in that series.
PMID:35886001 SUPPORT Human Clinical
"The most common associated genes were BBS10 (32.8%) and BBS1 (24.6%), and by far the most commonly observed variants were BBS10 c.271dup;p.C91Lfs*5 (21 alleles) and BBS1 c.1169T>G;p.M390R (18 alleles)."
This independent cohort confirms BBS1 as one of the two dominant genotype groups in contemporary clinical series.
BBS10 (Pathogenic biallelic variants)
Show evidence (3 references)
PMID:35886001 SUPPORT Human Clinical
"The most common associated genes were BBS10 (32.8%) and BBS1 (24.6%), and by far the most commonly observed variants were BBS10 c.271dup;p.C91Lfs*5 (21 alleles) and BBS1 c.1169T>G;p.M390R (18 alleles)."
This German cohort identifies BBS10 as the most common genotype in that series.
PMID:28143435 SUPPORT Human Clinical
"BBS10 was associated with the worse outcome in terms of the renal, ocular and audiovestibular phenotypes."
This cohort supports recording BBS10 as a genotype associated with more severe multisystem disease.
PMID:21209035 SUPPORT Human Clinical
"BBS1 (27%) and BBS10 (30%) mutations were the most prevalent."
This metabolic cohort independently confirms BBS10 as one of the most prevalent genotypes.
Other established BBS genes (Pathogenic biallelic variants)
Show evidence (2 references)
PMID:30614526 SUPPORT Human Clinical
"Molecular diagnosis during pregnancies remains a timely challenge for this heterogeneous disease (22 known genes)."
This large molecularly confirmed series supports broad genetic heterogeneity within classic BBS.
PMID:41219488 SUPPORT Human Clinical
"Biallelic pathogenic variants were identified in all patients, including three novel variants in the ARL6/BBS3, BBS9, and BBS10 genes, observed in four patients, including two siblings."
This recent cohort shows that clinically confirmed BBS continues to arise from multiple non-BBS1 genotypes.
💊

Treatments

2
Setmelanotide
Action: pharmacotherapy MAXO:0000058
Agent: setmelanotide
MC4R agonist pharmacotherapy that bypasses upstream ciliopathy-related satiety-pathway dysfunction and reduces bodyweight in Bardet-Biedl syndrome.
Target Phenotypes: obesity
Show evidence (2 references)
PMID:36356613 SUPPORT Human Clinical
"32·3% (95% CI 16·7 to 51·4; p=0·0006) of patients aged 12 years or older with Bardet-Biedl syndrome reached at least a 10% reduction in bodyweight after 52 weeks of setmelanotide."
This phase 3 trial provides direct evidence that MC4R agonism can reduce bodyweight in BBS.
PMID:36356613 SUPPORT Human Clinical
"These results support the use of setmelanotide and provided the necessary evidence for approval of this drug as the first treatment for obesity in patients with Bardet-Biedl syndrome."
The trial interpretation explicitly supports setmelanotide as the approved obesity-directed treatment for BBS.
Kidney transplantation
Action: organ transplantation MAXO:0010039
Organ transplantation is a viable treatment option for the subset of BBS patients who progress to end-stage renal disease.
Show evidence (1 reference)
PMID:27245600 SUPPORT Human Clinical
"Although the frequency of obesity and other manifestations of the metabolic syndrome warrant meticulous management in this high-risk population, favorable long-term outcomes suggest that renal transplantation is a viable option for patients with BBS and ESRD."
This registry-based transplant study supports kidney transplantation for the ESRD subset of BBS.
🔬

Biochemical Markers

1
Leptin (Increased)
Show evidence (1 reference)
PMID:21209035 SUPPORT Human Clinical
"Patients with BBS had higher leptin than expected for their degree of adiposity, consistent with the notion that ciliopathy-induced leptin signaling dysfunction is associated with leptin resistance."
This metabolic study supports hyperleptinemia as a human biochemical correlate of leptin resistance in BBS.
{ }

Source YAML

click to show
name: Bardet-Biedl syndrome
creation_date: "2025-12-04T16:57:31Z"
updated_date: "2026-04-13T01:21:32Z"
category: Mendelian
description: >-
  Bardet-Biedl syndrome is a genetically heterogeneous autosomal recessive
  ciliopathy caused by biallelic pathogenic variants in established BBS genes
  encoding the BBSome, its chaperonin-like assembly machinery, and closely
  related ciliary trafficking proteins. The core disease logic is failure of
  primary-cilium cargo trafficking, producing retinal degeneration, early-onset
  obesity with hyperphagia, postaxial polydactyly, and structurally and
  functionally abnormal kidneys.
disease_term:
  preferred_term: Bardet-Biedl syndrome
  term:
    id: MONDO:0015229
    label: Bardet-Biedl syndrome
classifications:
  harrisons_chapter:
  - classification_value: hereditary disease
  mechanistic_category:
  - classification_value: ciliopathy
parents:
- Syndromic Obesity
- Ciliopathy
synonyms:
- BBS
notes: >-
  This entry is framed at the classic syndrome level rather than split into a
  large number of gene-specific diseases. Gene-specific differences such as
  relatively milder BBS1 disease and more severe BBS10 renal and ocular disease
  are recorded as genotype-phenotype observations, while noncanonical
  "BBS-like" phenocopies are not merged automatically into this file.
inheritance:
- name: Autosomal recessive inheritance
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >-
    Classic Bardet-Biedl syndrome is an autosomal recessive syndromic
    ciliopathy.
  evidence:
  - reference: PMID:20876674
    reference_title: "Bardet-Biedl syndrome: a study of the renal and cardiovascular phenotypes in a French cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Bardet-Biedl Syndrome (BBS) is a rare autosomal recessive ciliopathy with a
      wide spectrum of clinical features including obesity, retinitis pigmentosa,
      polydactyly, mental retardation, hypogonadism, and renal abnormalities.
    explanation: >-
      This cohort abstract explicitly states autosomal recessive inheritance for
      classic BBS.
prevalence:
- population: European populations
  percentage: 1 in 160,000
  notes: >-
    Founder populations can be much more common; the same epidemiologic abstract
    cites prevalence as high as 1 in 13,000 in Kuwaiti Bedouins and estimated
    minimum prevalence of approximately 1 in 156,000 in Tunisia.
  evidence:
  - reference: PMID:22109794
    reference_title: "Prevalence of Bardet-Biedl syndrome in Tunisia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The prevalence of BBS has been estimated in different populations, ranging
      from 1 in 160,000 in European populations to 1 in 13,000 in Bedouins from
      Kuwait.
    explanation: >-
      This epidemiologic study provides a commonly cited prevalence range for
      BBS, including the European estimate used here.
genetic:
- name: BBS1
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: BBS1
    term:
      id: hgnc:966
      label: BBS1
  frequency: one of the most prevalent BBS genes
  notes: >-
    BBS1 is a recurrent cause of classic BBS; the common p.M390R allele is
    frequent in multiple cohorts and BBS1 disease can be milder than BBS10 in
    some series.
  evidence:
  - reference: PMID:28143435
    reference_title: "Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: identification of eleven novel pathogenic sequence variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The most common mutated gene was BBS1 followed by BBS10.
    explanation: >-
      This Italian cohort identifies BBS1 as the most common gene in that
      series.
  - reference: PMID:35886001
    reference_title: "Ophthalmic and Genetic Features of Bardet Biedl Syndrome in a German Cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The most common associated genes were BBS10 (32.8%) and BBS1 (24.6%), and
      by far the most commonly observed variants were BBS10 c.271dup;p.C91Lfs*5
      (21 alleles) and BBS1 c.1169T>G;p.M390R (18 alleles).
    explanation: >-
      This independent cohort confirms BBS1 as one of the two dominant genotype
      groups in contemporary clinical series.
- name: BBS10
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: BBS10
    term:
      id: hgnc:26291
      label: BBS10
  frequency: one of the most prevalent BBS genes
  notes: >-
    BBS10 is a common cause of BBS and is associated with more severe renal and
    ocular disease in some human cohorts.
  evidence:
  - reference: PMID:35886001
    reference_title: "Ophthalmic and Genetic Features of Bardet Biedl Syndrome in a German Cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The most common associated genes were BBS10 (32.8%) and BBS1 (24.6%), and
      by far the most commonly observed variants were BBS10 c.271dup;p.C91Lfs*5
      (21 alleles) and BBS1 c.1169T>G;p.M390R (18 alleles).
    explanation: >-
      This German cohort identifies BBS10 as the most common genotype in that
      series.
  - reference: PMID:28143435
    reference_title: "Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: identification of eleven novel pathogenic sequence variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      BBS10 was associated with the worse outcome in terms of the renal, ocular
      and audiovestibular phenotypes.
    explanation: >-
      This cohort supports recording BBS10 as a genotype associated with more
      severe multisystem disease.
  - reference: PMID:21209035
    reference_title: "Patients with Bardet-Biedl syndrome have hyperleptinemia suggestive of leptin resistance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      BBS1 (27%) and BBS10 (30%) mutations were the most prevalent.
    explanation: >-
      This metabolic cohort independently confirms BBS10 as one of the most
      prevalent genotypes.
- name: Other established BBS genes
  association: Pathogenic biallelic variants
  notes: >-
    Established disease genes extend beyond BBS1 and BBS10 and include core
    BBSome subunits and related ciliary trafficking genes such as BBS2,
    ARL6/BBS3, MKKS/BBS6, BBS9, and others.
  evidence:
  - reference: PMID:30614526
    reference_title: "Bardet-Biedl syndrome: Antenatal presentation of forty-five fetuses with biallelic pathogenic variants in known Bardet-Biedl syndrome genes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Molecular diagnosis during pregnancies remains a timely challenge for this
      heterogeneous disease (22 known genes).
    explanation: >-
      This large molecularly confirmed series supports broad genetic
      heterogeneity within classic BBS.
  - reference: PMID:41219488
    reference_title: "Comprehensive clinical and genetic characterization of Bardet-Biedl Syndrome: insights from the largest Turkish cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Biallelic pathogenic variants were identified in all patients, including
      three novel variants in the ARL6/BBS3, BBS9, and BBS10 genes, observed in
      four patients, including two siblings.
    explanation: >-
      This recent cohort shows that clinically confirmed BBS continues to arise
      from multiple non-BBS1 genotypes.
pathophysiology:
- name: Pathogenic BBS gene defects
  description: >-
    Biallelic pathogenic variants in established BBS genes initiate classic
    Bardet-Biedl syndrome.
  genes:
  - preferred_term: BBS1
    term:
      id: hgnc:966
      label: BBS1
  - preferred_term: BBS10
    term:
      id: hgnc:26291
      label: BBS10
  - preferred_term: BBS2
    term:
      id: hgnc:967
      label: BBS2
  - preferred_term: ARL6
    term:
      id: hgnc:13210
      label: ARL6
  - preferred_term: MKKS
    term:
      id: hgnc:7108
      label: MKKS
  evidence:
  - reference: PMID:30614526
    reference_title: "Bardet-Biedl syndrome: Antenatal presentation of forty-five fetuses with biallelic pathogenic variants in known Bardet-Biedl syndrome genes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Molecular diagnosis during pregnancies remains a timely challenge for this
      heterogeneous disease (22 known genes).
    explanation: >-
      This large prenatal molecular series supports disease initiation by
      biallelic pathogenic variants across many established BBS genes.
  - reference: PMID:41219488
    reference_title: "Comprehensive clinical and genetic characterization of Bardet-Biedl Syndrome: insights from the largest Turkish cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Biallelic pathogenic variants were identified in all patients, including
      three novel variants in the ARL6/BBS3, BBS9, and BBS10 genes, observed in
      four patients, including two siblings.
    explanation: >-
      This recent cohort confirms that clinically diagnosed BBS is anchored by
      biallelic pathogenic variants in established BBS genes.
  downstream:
  - target: Defective BBSome assembly
    description: Disease-causing variants destabilize the BBSome or its assembly machinery.
- name: Defective BBSome assembly
  description: >-
    Pathogenic variants in core BBSome subunits and chaperonin-like BBS proteins
    impair ordered assembly of the BBSome, the ciliary trafficking complex
    central to BBS biology.
  cellular_components:
  - preferred_term: BBSome
    term:
      id: GO:0034464
      label: BBSome
  - preferred_term: primary cilium
    term:
      id: GO:0005929
      label: cilium
  evidence:
  - reference: PMID:22500027
    reference_title: "Intrinsic protein-protein interaction-mediated and chaperonin-assisted sequential assembly of stable bardet-biedl syndrome protein complex, the BBSome."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Three additional BBS genes (BBS6, BBS10, and BBS12) have homology to type
      II chaperonins and interact with CCT/TRiC proteins and BBS7 to form a
      complex termed the BBS-chaperonin complex. This complex is required for
      BBSome assembly.
    explanation: >-
      This mechanistic study directly supports chaperonin-dependent failure of
      BBSome assembly as an early causal step in BBS.
  - reference: PMID:20080638
    reference_title: "BBS6, BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and mediate BBSome assembly."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Our data demonstrate that BBS6, BBS10, and BBS12 are necessary for BBSome
      assembly, and that impaired BBSome assembly contributes to the etiology of
      BBS phenotypes associated with the loss of function of these three BBS
      genes.
    explanation: >-
      This complementary paper independently supports BBSome assembly failure as
      a proximal disease mechanism.
  downstream:
  - target: Ciliary membrane protein trafficking defect
    description: An incompletely assembled BBSome fails to move selected cargos correctly through the ciliary compartment.
- name: Ciliary membrane protein trafficking defect
  description: >-
    Failure of an intact BBSome disrupts trafficking of signaling proteins and
    other cargos into and within the ciliary compartment.
  cellular_components:
  - preferred_term: primary cilium
    term:
      id: GO:0005929
      label: cilium
  biological_processes:
  - preferred_term: protein localization to cilium
    term:
      id: GO:0061512
      label: protein localization to cilium
  - preferred_term: intraciliary transport
    term:
      id: GO:0042073
      label: intraciliary transport
  evidence:
  - reference: PMID:36699005
    reference_title: "Ciliary signaling proteins are mislocalized in the brains of Bardet-Biedl syndrome 1-null mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      GPCR ciliary localization is disrupted in neurons from mouse models of the
      ciliopathy Bardet-Biedl syndrome, with GPCRs failing to localize to cilia,
      indicating the Bardet-Biedl syndrome proteins are required for trafficking
      of G protein-coupled receptors into neuronal cilia.
    explanation: >-
      This mouse study directly supports defective ciliary cargo trafficking as a
      general mechanistic consequence of BBS protein loss.
  downstream:
  - target: Hypothalamic leptin receptor signaling defect
    description: Impaired neuronal ciliary trafficking perturbs hypothalamic satiety signaling.
  - target: Photoreceptor outer-segment transport defect
    description: High-throughput photoreceptor cargo delivery fails when ciliary trafficking is disrupted.
  - target: Renal tubulointerstitial injury
    description: Kidney epithelial cilia-dependent homeostasis is disrupted downstream of trafficking failure.
  - target: Altered Sonic hedgehog-dependent limb patterning
    description: Developmental ciliary signaling defects perturb limb-bud patterning.
- name: Hypothalamic leptin receptor signaling defect
  description: >-
    BBS proteins are required for leptin-receptor trafficking and
    leptin-induced hypothalamic signaling, creating ciliary leptin resistance
    and impaired satiety signaling.
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  locations:
  - preferred_term: hypothalamus
    term:
      id: UBERON:0001898
      label: hypothalamus
  biological_processes:
  - preferred_term: JAK-STAT signaling
    term:
      id: GO:0007259
      label: cell surface receptor signaling pathway via JAK-STAT
  evidence:
  - reference: PMID:19150989
    reference_title: "Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Our data indicate that BBS proteins mediate LepR trafficking and that
      impaired LepR signaling underlies energy imbalance in BBS.
    explanation: >-
      This mouse study directly connects BBS-protein loss to defective
      hypothalamic leptin receptor trafficking and signaling.
  - reference: PMID:21209035
    reference_title: "Patients with Bardet-Biedl syndrome have hyperleptinemia suggestive of leptin resistance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients with BBS had higher leptin than expected for their degree of
      adiposity, consistent with the notion that ciliopathy-induced leptin
      signaling dysfunction is associated with leptin resistance.
    explanation: >-
      Human metabolic data support leptin resistance as a clinically observable
      consequence of BBS-related satiety-pathway dysfunction.
  downstream:
  - target: Hyperphagia
    description: Impaired satiety signaling increases hunger and food-seeking behavior.
  - target: Obesity
    description: Chronic positive energy balance drives early-onset obesity.
- name: Photoreceptor outer-segment transport defect
  description: >-
    In photoreceptors, defective ciliary transport mislocalizes rhodopsin and
    other outer-segment cargo, leading to photoreceptor degeneration.
  cell_types:
  - preferred_term: photoreceptor cell
    term:
      id: CL:0000210
      label: photoreceptor cell
  locations:
  - preferred_term: retina
    term:
      id: UBERON:0000966
      label: retina
  cellular_components:
  - preferred_term: photoreceptor outer segment
    term:
      id: GO:0001750
      label: photoreceptor outer segment
  evidence:
  - reference: PMID:15539463
    reference_title: "Bbs2-null mice have neurosensory deficits, a defect in social dominance, and retinopathy associated with mislocalization of rhodopsin."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Photoreceptor cell death is preceded by mislocalization of rhodopsin,
      indicating a defect in transport.
    explanation: >-
      This model-organism study directly ties BBS-related transport failure to
      the retinal degeneration branch of the disease.
  downstream:
  - target: Rod-cone dystrophy
    description: Photoreceptor degeneration produces the invariant retinal dystrophy phenotype.
  - target: Progressive visual loss
    description: Ongoing photoreceptor loss causes worsening visual acuity over time.
- name: Renal tubulointerstitial injury
  description: >-
    Kidney involvement in BBS includes renal dysmorphism, impaired kidney
    function, and chronic tubulointerstitial disease consistent with a renal
    ciliopathy.
  cell_types:
  - preferred_term: nephron tubule epithelial cell
    term:
      id: CL:1000494
      label: nephron tubule epithelial cell
  locations:
  - preferred_term: kidney
    term:
      id: UBERON:0002113
      label: kidney
  evidence:
  - reference: PMID:20876674
    reference_title: "Bardet-Biedl syndrome: a study of the renal and cardiovascular phenotypes in a French cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Renal abnormalities, including impairment of renal function and signs of
      chronic interstitial nephropathy of dysplastic nature, were documented in
      82% of the patients.
    explanation: >-
      This human cohort provides direct tissue-level support for renal
      tubulointerstitial disease within BBS.
  downstream:
  - target: Renal abnormalities
    description: Structural and functional kidney disease is a major clinical consequence.
- name: Altered Sonic hedgehog-dependent limb patterning
  description: >-
    BBS loss perturbs cilia-dependent Sonic hedgehog signaling during limb-bud
    development, predisposing to postaxial digit duplication.
  biological_processes:
  - preferred_term: smoothened signaling pathway
    term:
      id: GO:0007224
      label: smoothened signaling pathway
  locations:
  - preferred_term: limb bud
    term:
      id: UBERON:0004347
      label: limb bud
  evidence:
  - reference: PMID:18381349
    reference_title: "Genetic interaction between Bardet-Biedl syndrome genes and implications for limb patterning."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      We evaluated zebrafish fin bud patterning and observed altered Sonic
      hedgehog (shh) expression and subsequent changes to fin skeletal elements.
    explanation: >-
      This in vivo developmental study supports altered hedgehog-dependent limb
      patterning as the mechanistic basis for BBS polydactyly.
  downstream:
  - target: Postaxial polydactyly
    description: Disrupted limb-bud patterning manifests clinically as postaxial extra digits.
phenotypes:
- name: Rod-cone dystrophy
  category: Ocular
  frequency: VERY_FREQUENT
  diagnostic: true
  description: >-
    Invariant retinal dystrophy with early rod dysfunction, progressive retinal
    degeneration, and severe visual morbidity over time.
  phenotype_term:
    preferred_term: rod-cone dystrophy
    term:
      id: HP:0000510
      label: Rod-cone dystrophy
  evidence:
  - reference: PMID:35886001
    reference_title: "Ophthalmic and Genetic Features of Bardet Biedl Syndrome in a German Cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All patients had retinal dystrophy with morphologic changes of the retina.
    explanation: >-
      This specialist ophthalmic cohort supports retinal dystrophy as an
      essentially invariant feature of molecularly confirmed BBS.
  - reference: PMID:41219488
    reference_title: "Comprehensive clinical and genetic characterization of Bardet-Biedl Syndrome: insights from the largest Turkish cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Retinal dystrophy was the most common feature (94.1%), followed by
      polydactyly (88.0%), obesity (68.0%), and renal anomalies (52.0%).
    explanation: >-
      This recent cohort provides direct frequency support for a very frequent
      retinal dystrophy phenotype.
- name: Progressive visual loss
  category: Ocular
  description: >-
    Visual acuity progressively declines from childhood, often reaching severe
    impairment or blindness in later decades.
  phenotype_term:
    preferred_term: progressive visual loss
    term:
      id: HP:0000529
      label: Progressive visual loss
  evidence:
  - reference: PMID:35886001
    reference_title: "Ophthalmic and Genetic Features of Bardet Biedl Syndrome in a German Cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Visual acuity decreased from ~0.2 (decimal) at age 5 to blindness 0 at 50
      years.
    explanation: >-
      This cohort provides direct longitudinal-style evidence for progressive
      loss of vision across the lifespan in BBS.
  - reference: PMID:22358239
    reference_title: "Visual acuity and retinal function in patients with Bardet-Biedl syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In a relatively young cohort of patients with Bardet-Biedl syndrome, only
      21% had 20/40 or better vision.
    explanation: >-
      This retinal-function study supports clinically important visual loss even
      in a relatively young cohort.
- name: Obesity
  category: Metabolic
  frequency: FREQUENT
  description: >-
    Rapid early-childhood weight gain leads to persistent overweight or obesity
    through childhood and adulthood.
  phenotype_term:
    preferred_term: obesity
    term:
      id: HP:0001513
      label: Obesity
  evidence:
  - reference: PMID:32700463
    reference_title: "Bardet-Biedl syndrome: Weight patterns and genetics in a rare obesity syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Despite normal birth weight, most individuals with BBS experience rapid
      weight gain in early childhood, with high rates of overweight/obesity
      sustained through adolescence.
    explanation: >-
      This large registry-based pediatric study supports obesity as a core and
      early feature of BBS.
  - reference: PMID:41219488
    reference_title: "Comprehensive clinical and genetic characterization of Bardet-Biedl Syndrome: insights from the largest Turkish cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Retinal dystrophy was the most common feature (94.1%), followed by
      polydactyly (88.0%), obesity (68.0%), and renal anomalies (52.0%).
    explanation: >-
      This recent cohort provides direct frequency support for obesity as a
      frequent BBS phenotype.
- name: Hyperphagia
  category: Behavioral
  description: >-
    Pathologic hunger and food-seeking behavior contribute to the obesity burden
    in BBS.
  phenotype_term:
    preferred_term: hyperphagia
    term:
      id: HP:0002591
      label: Polyphagia
  evidence:
  - reference: PMID:23776152
    reference_title: "Hyperphagia among patients with Bardet-Biedl syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Total hyperphagia questionnaire score was higher in BBS than controls
      (27.6 ± 9.0 vs. 19.1 ± 7.9, P = 0.005).
    explanation: >-
      This controlled study shows that hyperphagic symptoms are increased in BBS
      relative to BMI-matched controls.
- name: Postaxial polydactyly
  category: Skeletal
  frequency: FREQUENT
  diagnostic: true
  description: >-
    Postaxial extra digits affecting hands or feet are a cardinal developmental
    manifestation of BBS.
  phenotype_term:
    preferred_term: postaxial polydactyly
    term:
      id: HP:0100259
      label: Postaxial polydactyly
  evidence:
  - reference: PMID:41219488
    reference_title: "Comprehensive clinical and genetic characterization of Bardet-Biedl Syndrome: insights from the largest Turkish cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Retinal dystrophy was the most common feature (94.1%), followed by
      polydactyly (88.0%), obesity (68.0%), and renal anomalies (52.0%).
    explanation: >-
      This recent cohort provides direct frequency support for polydactyly as a
      frequent primary BBS feature.
  - reference: PMID:30614526
    reference_title: "Bardet-Biedl syndrome: Antenatal presentation of forty-five fetuses with biallelic pathogenic variants in known Bardet-Biedl syndrome genes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      postaxial polydactyly (82%) and renal cysts (78%) were the most prevalent
      symptoms.
    explanation: >-
      This large molecularly confirmed prenatal cohort provides independent
      support for frequent postaxial polydactyly.
- name: Renal abnormalities
  category: Genitourinary
  frequency: FREQUENT
  description: >-
    Structural and functional kidney disease includes renal dysmorphism, cystic
    or dysplastic change, and impaired kidney function.
  phenotype_term:
    preferred_term: renal abnormalities
    term:
      id: HP:0000077
      label: Abnormality of the kidney
  evidence:
  - reference: PMID:20876674
    reference_title: "Bardet-Biedl syndrome: a study of the renal and cardiovascular phenotypes in a French cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Renal abnormalities, including impairment of renal function and signs of
      chronic interstitial nephropathy of dysplastic nature, were documented in
      82% of the patients.
    explanation: >-
      This national cohort supports renal involvement as a frequent and
      clinically important component of BBS.
  - reference: PMID:41219488
    reference_title: "Comprehensive clinical and genetic characterization of Bardet-Biedl Syndrome: insights from the largest Turkish cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Retinal dystrophy was the most common feature (94.1%), followed by
      polydactyly (88.0%), obesity (68.0%), and renal anomalies (52.0%).
    explanation: >-
      This recent cohort confirms that renal involvement remains common but more
      variable than retinal disease or polydactyly.
biochemical:
- name: Leptin
  presence: Increased
  biomarker_term:
    preferred_term: leptin measurement
    term:
      id: NCIT:C74866
      label: Leptin Measurement
  notes: >-
    Serum leptin is elevated beyond what would be expected for adiposity alone,
    supporting clinical leptin resistance.
  evidence:
  - reference: PMID:21209035
    reference_title: "Patients with Bardet-Biedl syndrome have hyperleptinemia suggestive of leptin resistance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients with BBS had higher leptin than expected for their degree of
      adiposity, consistent with the notion that ciliopathy-induced leptin
      signaling dysfunction is associated with leptin resistance.
    explanation: >-
      This metabolic study supports hyperleptinemia as a human biochemical
      correlate of leptin resistance in BBS.
treatments:
- name: Setmelanotide
  description: >-
    MC4R agonist pharmacotherapy that bypasses upstream ciliopathy-related
    satiety-pathway dysfunction and reduces bodyweight in Bardet-Biedl syndrome.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
    therapeutic_agent:
    - preferred_term: setmelanotide
      term:
        id: NCIT:C152349
        label: Setmelanotide
  target_phenotypes:
  - preferred_term: obesity
    term:
      id: HP:0001513
      label: Obesity
  evidence:
  - reference: PMID:36356613
    reference_title: "Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      32·3% (95% CI 16·7 to 51·4; p=0·0006) of patients aged 12 years or older
      with Bardet-Biedl syndrome reached at least a 10% reduction in bodyweight
      after 52 weeks of setmelanotide.
    explanation: >-
      This phase 3 trial provides direct evidence that MC4R agonism can reduce
      bodyweight in BBS.
  - reference: PMID:36356613
    reference_title: "Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These results support the use of setmelanotide and provided the necessary
      evidence for approval of this drug as the first treatment for obesity in
      patients with Bardet-Biedl syndrome.
    explanation: >-
      The trial interpretation explicitly supports setmelanotide as the approved
      obesity-directed treatment for BBS.
- name: Kidney transplantation
  description: >-
    Organ transplantation is a viable treatment option for the subset of BBS
    patients who progress to end-stage renal disease.
  treatment_term:
    preferred_term: organ transplantation
    term:
      id: MAXO:0010039
      label: organ transplantation
  evidence:
  - reference: PMID:27245600
    reference_title: "Renal transplantation in Bardet-Biedl Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Although the frequency of obesity and other manifestations of the
      metabolic syndrome warrant meticulous management in this high-risk
      population, favorable long-term outcomes suggest that renal
      transplantation is a viable option for patients with BBS and ESRD.
    explanation: >-
      This registry-based transplant study supports kidney transplantation for
      the ESRD subset of BBS.